Loss of p16 and/or pRb protein expression in NSCLC
- 1 March 2001
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 31 (2-3) , 163-170
- https://doi.org/10.1016/s0169-5002(00)00191-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significanceThe Journal of Pathology, 1999
- A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancersCancer Letters, 1998
- Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancersInternational Journal of Cancer, 1998
- Role of the p16 tumor suppressor gene in cancer.Journal of Clinical Oncology, 1998
- Mechanisms of p16INK4A inactivation in non small-cell lung cancersOncogene, 1998
- Role of the retinoblastoma protein in the pathogenesis of human cancer.Journal of Clinical Oncology, 1997
- G1 control gene status is frequently altered in resectable non-small cell lung cancerInternational Journal of Cancer, 1997
- Cancer Cell CyclesScience, 1996
- Compilation of somatic mutations of theCDKN2 gene in human cancers: Non-random distribution of base substitutionsGenes, Chromosomes and Cancer, 1996
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995